UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 3)*
(Name of Issuer)
Common Stock, par value $0.001
(Title of Class of Securities)
(CUSIP Number)
Sam P. Douglass
3229 Groveland Lane
Houston, Texas 77019
and
Paula T. Douglass
3229 Groveland Lane
Houston, Texas 77019
(713) 526-9000
(Name, Address and Telephone Number of Person Authorized to
Receive Notices and Communications)
(Date of Event Which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. o
Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.
* The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
EXPLANATORY NOTE
This Amendment No. 3 to Schedule 13D (this Amendment), among other things, amends and
supplements the Schedule 13D originally filed by Sam P. Douglass and Equus Corporation
International on May 27, 1997, as amended by Amendment No. 1 thereto filed on June 4, 2009 and
Amendment No. 2 thereto filed on November 27, 2009 (the Schedule 13D).
Unless set forth below, all previous Items of the Schedule 13D are unchanged. Capitalized
terms used herein which are not defined herein have the meanings set forth in the Schedule 13D.
Item 4. Purpose of Transaction.
Item 4 of the Schedule 13D is hereby amended and restated in its entirety, with effect from the
date of this Amendment, as follows:
The Reporting Persons no longer intend to solicit proxies from the Issuers stockholders for
use at the Issuers next annual meeting in order to seek election of their nominees to the Board.
This decision was made following discussions with members of the Board relating to the matters of
concern reported in Amendment No. 2 to Schedule 13D, the recent creation by the Board of an
executive committee, whose members include Mr. Douglass and four of the Issuers independent
directors, and the Issuers implementation of certain Board and management changes as announced in
the Issuers press release dated February 19, 2010. The Reporting Persons currently do not have any
other plans or proposals that relate to or would result in any of the actions required to be
described in clauses (a) through (j) of Item 4 of Schedule 13D. The Reporting Persons intend to
review their investments in the Issuer on a continuing basis and, depending upon the price and
availability of the Issuers securities, subsequent developments concerning the Issuer, the
Issuers business and prospects, general market and economic conditions and other factors deemed
relevant, may decide at any time to reconsider or reformulate their position, plans or proposals
with respect to the Issuer. Such positions, plans or proposals may relate to one or more of the
transactions specified in clauses (a) through (j) of Item 4 of Schedule 13D, including, without
limitation, acquiring additional securities of the Issuer or selling any or all of the securities
of the Issuer that they hold.
Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the
Issuer.
Item 6 of the Schedule 13D is hereby amended and restated in its entirety, with effect from the
date of this Amendment, as follows:
See the discussion of MCCAs obligations under the ECMC Purchase referenced in Item 3 of
Amendment No. 1 to Schedule 13D.
Except for the relationship of Sam P. Douglass as a director of the Issuer, the relationship
of Paula T. Douglass, the wife of Sam P. Douglass, as an officer of the Issuer, and as otherwise
described in prior Amendments Nos. 1 or 2 or this Amendment, there are no contracts, arrangements,
understandings or relationships (legal or otherwise) among the Reporting Persons and any other
person with respect to any securities of the Issuer, including, but not limited to, transfer or
voting of any of the Common Stock, finders fees, joint ventures, loan or option arrangements, put
or calls, guarantees of profits, division of profits or loss, or the giving or withholding of
proxies.
In accordance with Rule 13d-4 promulgated under the Securities Exchange Act of 1934, as
amended, each Reporting Person expressly declares that the filing of this statement shall not be
construed as an admission that he, she or it is, for purposes of Section 13(d) or Section 13(g) of
such Act, the beneficial owner of any securities of the Issuer other than as expressly described in
Item 5 (including the notes thereto).
1